Digi­tal com­mu­ni­ca­ti­on chan­nels are sub­ject to the moni­to­ring obli­ga­ti­on of drug safe­ty (phar­ma­co­vi­gi­lan­ce) just like con­ven­tio­nal chan­nels. Howe­ver, the num­e­rous new chan­nels of com­mu­ni­ca­ti­on can only be moni­to­red in con­for­mi­ty with the law with pro­found tech­ni­cal know­ledge, cou­pled with the know-how of pharmacovigilance.

An important ele­ment of phar­ma­co­vi­gi­lan­ce is the report­ing of adver­se drug reac­tions (ADRs) to the com­pe­tent authorities.

Regard­less of which digi­tal pro­ject you would like to imple­ment, we would be hap­py to take over the moni­to­ring for you, in a high­ly effi­ci­ent and eco­no­mic­al manor.

By using our phar­ma­co­vi­gi­lan­ce ser­vice soft­ware eva­lii, we offer the audit-com­pli­ant, effi­ci­ent, and safe solu­ti­on to moni­tor even high-fre­quen­cy channels.

We now offer this ser­vice in 41 count­ries. Cont­act us for fur­ther infor­ma­ti­on or find out more at: